Browse Data and Analysis
Filter
Search Data and Analysis
- 668 results found
- (-) Cotton and Hemp
- Clear all
Post forecasts MY14/15 lint production at 4.3 million bales. Generally favorable weather conditions are countered by irrigation water deficit in the South and some pest problems in several regions.
In the past decade, India has emerged as a major agricultural exporter, with exports climbing from just over $5 billion in 2003 to a record of more than $39 billion in 2013.
Minister of Science and Technology approved revised regulations that will create a positive environment for seed companies to start research.
The U.S-Mexico ag trade relationship is broad and deep, with opportunities to further integrate our rural economies while supplying desired products to consumers in both countries year-round.
Although Ecuador maintains a number of anti-biotech laws and regulations, there is minimal enforcement, and trade in cotton and soybean products continues.
Mozambique is revising its biosafety regulations, which could allow for the country's first field trials of genetically engineered crops.
Information on the Egyptian market for U.S. exporters of food and agricultural products. Prospects for U.S. bulk commodities and intermediate products remain positive in 2013.
Brazil is the world's second-largest producer of biotech crops. Post forecasts a 10-percent increase in area planted to biotech crops in the upcoming 2013/14 Brazilian crop year (October-September).
China is expected to remain a significant importer of biotech products and may become an exporter of biotechnology in the medium to long term.
Colombia continues to expand its biotechnology frontier. The adoption rate for biotech corn has surpassed that of cotton and the development of a regulatory framework is underway.
Recent high-profile activism against biotechnology has created uncertainty among those involved in production and research of biotechnology products in Costa Rica.
El Salvador has no legal restriction on the use of agricultural biotechnology. However the country's biotech regulatory framework is still being developed.